CONNEQT Health Limited (CQT.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.01 (+0.00%) as of
Key statistics
- Market cap
- 10.16M
- EPS (TTM)
- -0.0200
- Dividend yield
- 0.00%
- 52-week range
- 0.0100 – 0.0640
- Beta
- 0.51
- Revenue (TTM)
- 7.9M
- Profit margin
- -137.50%
- Volume
- 1.99M
About CONNEQT Health Limited
CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biomarker platform that captures a peripheral arterial waveform from the upper-arm, wrist, or finger and convert it to a central pressure waveform to extract vascular biomarkers. The company also provides medical and home health care devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders. It sells its cardiovascular devices and services to individuals, hospitals, clinics, research institutions and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to CONNEQT Health Limited in September 2025. CONNEQT Health Limited was founded in 1994 and is based in Sydney, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Sydney, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.